Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1496, New York, NY 10029, USA; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1496, New York, NY 10029, USA; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Largo Marquês do Pombal 3004-517, Coimbra, Portugal; Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal 3004-517, Coimbra, Portugal.
Skolkovo Institute of Science and Technology, Nobel Street, Building 3, Moscow 143026, Russia.
Cell Rep. 2018 Dec 4;25(10):2821-2835.e7. doi: 10.1016/j.celrep.2018.11.032.
During development, hematopoietic stem and progenitor cells (HSPCs) arise from specialized endothelial cells by a process termed endothelial-to-hematopoietic transition (EHT). The genetic program driving human HSPC emergence remains largely unknown. We previously reported that the generation of hemogenic precursor cells from mouse fibroblasts recapitulates developmental hematopoiesis. Here, we demonstrate that human fibroblasts can be reprogrammed into hemogenic cells by the same transcription factors. Induced cells display dynamic EHT transcriptional programs, generate hematopoietic progeny, possess HSPC cell surface phenotype, and repopulate immunodeficient mice for 3 months. Mechanistically, GATA2 and GFI1B interact and co-occupy a cohort of targets. This cooperative binding is reflected by engagement of open enhancers and promoters, initiating silencing of fibroblast genes and activating the hemogenic program. However, GATA2 displays dominant and independent targeting activity during the early phases of reprogramming. These findings shed light on the processes controlling human HSC specification and support generation of reprogrammed HSCs for clinical applications.
在发育过程中,造血干/祖细胞(HSPCs)由特定的内皮细胞通过内皮细胞向造血细胞过渡(EHT)过程产生。驱动人类 HSPC 出现的遗传程序在很大程度上仍然未知。我们之前报道过,从小鼠成纤维细胞中产生造血前体细胞可以重现发育中的造血过程。在这里,我们证明相同的转录因子可以将人类成纤维细胞重编程为造血细胞。诱导细胞显示出动态的 EHT 转录程序,产生造血祖细胞,具有 HSPC 细胞表面表型,并在免疫缺陷小鼠中重新定植 3 个月。从机制上讲,GATA2 和 GFI1B 相互作用并共同占据了一群靶标。这种协同结合反映在开放增强子和启动子的参与上,启动了成纤维细胞基因的沉默和造血程序的激活。然而,GATA2 在重编程的早期阶段表现出主导和独立的靶向活性。这些发现揭示了控制人类 HSC 特化的过程,并支持了用于临床应用的重编程 HSC 的产生。